Exane Derivatives’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.32M | Buy |
|
|||||
|
2022
Q1 | $791K | Sell |
|
|||||
|
2021
Q4 | $1.38M | Buy |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2021
Q2 | $1.18M | Sell |
|
|||||
|
2021
Q1 | $1.18M | Sell |
|
|||||
|
2020
Q4 | $1.18M | Sell |
|
|||||
|
2020
Q3 | $2.21M | Buy |
|
|||||
|
2020
Q2 | $1.09M | Sell |
|
|||||
|
2020
Q1 | $1.2M | Sell |
|
|||||
|
2019
Q4 | $1.49M | Buy |
|
|||||
|
2019
Q3 | $806K | Buy |
|
|||||
|
2019
Q2 | $258K | Sell |
|
|||||
|
2019
Q1 | $673K | Sell |
|
|||||
|
2018
Q4 | $1.41M | Buy |
|
|||||
|
2018
Q3 | $293K | Sell |
|
|||||
|
2018
Q2 | $626K | Buy |
|
|||||
|
2018
Q1 | $309K | Buy |
|
|||||
|
2017
Q4 | $286K | Buy |
|
|||||
|
2017
Q3 | $230K | Sell |
|
|||||
|
2017
Q2 | $313K | Sell |
|
|||||
|
2017
Q1 | $391K | Buy |
|
|||||
|
2016
Q4 | $103K | Sell |
|
|||||
|
2016
Q3 | $870K | Buy |
|
|||||
|
2016
Q2 | $194K | Sell |
|
|||||
|
2016
Q1 | $329K | Buy |
|
|||||
|
2015
Q4 | $296K | Buy |
|
|||||
|
2015
Q3 | $147K | Buy |
|
|||||
|
2015
Q2 | $72.5K | Hold |
|
|||||
|
2015
Q1 | $70.3K | Sell |
|
|||||
|
2014
Q4 | $159K | Buy |
|